Acura Pharmaceuticals Inc ACUR:OTCPK

RT Quote | Exchange | USD
Last | 05/20/22 EDT
0.348UNCH (UNCH)
Volume
20
52 week range
0.29 - 0.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.348
  • 52 Week High0.75
  • 52 Week High Date06/23/21
  • 52 Week Low0.29
  • 52 Week Low Date03/08/22

Key Stats

  • Market Cap22.65M
  • Shares Out65.09M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change-30.4

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.348
  • 52 Week High0.75
  • 52 Week High Date06/23/21
  • 52 Week Low0.29
  • 52 Week Low Date03/08/22
  • Market Cap22.65M
  • Shares Out65.09M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.60
  • YTD % Change-30.4

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-12.44
  • Fwd P/E (NTM)-2.90
  • EBITDA (TTM)-1.033M
  • ROE (TTM)13,209.72%
  • Revenue (TTM)2.25M
  • Gross Margin (TTM)4.20%
  • Net Margin (TTM)-51.27%
  • Debt To Equity (MRQ)240.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acura Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acura Pharmaceuticals, Inc. is a drug delivery company that is engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. The Company has discovered and developed approximately three platform technologies, which can be used to develop multiple products. The Company's Oxaydo Tablets (oxycodone HCl, CII), which utilizes the Aversion Technology, is an approved and immediate-release (IR) oxycodone product...
Robert Jones
President, Chief Executive Officer, Director
Peter Clemens
Chief Financial Officer, Senior Vice President, Secretary
Albert Brzeczko Ph.D.
Vice President - Pharmaceutical Sciences
Robert Seiser
Vice President, Corporate Controller, Treasurer
James Emigh
Vice President - Corporate Development
Address
616 N North Ct Ste 120
Palatine, IL
60067-8121
United States

Top Peers

SYMBOLLASTCHG%CHG
NAVB
Navidea Biopharmaceuticals Inc
0.8173+0.0019+0.23%
CYTH
Cyclo Therapeutics Inc
2.10+0.12+6.06%
TMBR
Timber Pharmaceuticals Inc
0.2586-0.002-0.7675%
ACRX
AcelRx Pharmaceuticals Inc
0.2581+0.0031+1.22%
EVOK
Evoke Pharma Inc
2.72-0.35-11.52%